Abstract
To achieve therapeutic effects, gene transportation or gene transfection becomes the key technique of gene therapy. Since viral vectors for gene therapy have shown serious problems, including immunogenicity and other adverse effects, non-viral carriers have attracted a great deal of attention, despite the fact that the transfection efficiencies are lower than those by viral carriers. Therefore, the major challenge of gene delivery is to improve the transfection efficiencies of the non-viral carriers, and first of all, the cell penetration efficiencies. This review focuses on recent approaches in the development of new non-viral gene delivery vectors, with great respect to those constructed based on cell penetration pathways of intracellular process considering transfection efficiency and cell penetration efficiency. Further development of sophisticated delivery systems is prospected for the non-viral vectors application in gene therapy.
Keywords: Gene delivery, Transfection efficiency, Pharmaceutical strategies, Non-viral vector, Cell penetration pathways
Current Gene Therapy
Title: Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Volume: 9 Issue: 4
Author(s): Chunxi Liu and Na Zhang
Affiliation:
Keywords: Gene delivery, Transfection efficiency, Pharmaceutical strategies, Non-viral vector, Cell penetration pathways
Abstract: To achieve therapeutic effects, gene transportation or gene transfection becomes the key technique of gene therapy. Since viral vectors for gene therapy have shown serious problems, including immunogenicity and other adverse effects, non-viral carriers have attracted a great deal of attention, despite the fact that the transfection efficiencies are lower than those by viral carriers. Therefore, the major challenge of gene delivery is to improve the transfection efficiencies of the non-viral carriers, and first of all, the cell penetration efficiencies. This review focuses on recent approaches in the development of new non-viral gene delivery vectors, with great respect to those constructed based on cell penetration pathways of intracellular process considering transfection efficiency and cell penetration efficiency. Further development of sophisticated delivery systems is prospected for the non-viral vectors application in gene therapy.
Export Options
About this article
Cite this article as:
Liu Chunxi and Zhang Na, Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems, Current Gene Therapy 2009; 9 (4) . https://dx.doi.org/10.2174/156652309788921053
DOI https://dx.doi.org/10.2174/156652309788921053 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Current Signal Transduction Therapy Multidrug Transporters as Drug Targets
Current Drug Targets Juglone Exerts Cytotoxic, Anti-proliferative and Anti-invasive Effects on Glioblastoma Multiforme in a Cell Culture Model
Anti-Cancer Agents in Medicinal Chemistry Kinins and Cardiovascular Diseases
Current Pharmaceutical Design The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Current Cancer Drug Targets Nanotechnology and Brain Tumors Drug Delivery
Recent Patents on Nanomedicine Genes that Modulate the Sensitivity for Anti-Microtubule Drug-Mediated Chemotherapy
Current Cancer Drug Targets Gold Nanoparticle-Based Drug Delivery Platform for Antineoplastic Chemotherapy
Current Drug Metabolism Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer’s disease
Current Topics in Medicinal Chemistry Therapeutic Gene Products Delivery by Neuron Stem Cells
Current Pharmaceutical Biotechnology Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Current Pharmaceutical Biotechnology Novel Superactive Leptin Antagonists and their Potential Therapeutic Applications
Current Pharmaceutical Design Epigenetics in Brain Tumors: HDACs Take Center Stage
Current Neuropharmacology Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
Current Pharmaceutical Design Clinical Trials with Intracerebral Convection-Enhanced Delivery of Targeted Toxins in Malignant Glioma
Reviews on Recent Clinical Trials The Urokinase Receptor as a Potential Target in Cancer Therapy
Current Pharmaceutical Design Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
Current Drug Targets - CNS & Neurological Disorders